Company: RGNT
Filing Date: 2025-01-24
Form Type: DRS
Source: 0001213900-25-006245
Chunk: 33

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-24
Form: DRS
Chunk 33
---
'>23</div>

We are highly dependent on key members of our executive management team. Our inability to retain these individuals could impede our business plan and growth strategies, which could have a negative impact on our business and the value of your investment.

Our ability to implement our
business plan depends on the continued services of key members of our senior management. In particular, and to a critical extent, we are
dependent on the continued efforts and services of the members of management named in the “Management”. If we lose the services
of such key members of our management team, we would likely be forced to expend significant time and money in the pursuit of replacement
individuals, which may result in a delay in the implementation of our business plan and plan of operations. We may not be able to find
satisfactory replacements on terms that would not be unduly expensive or burdensome to us. We do not currently carry a key-man life insurance
policy that would assist us in recouping our costs in the event of the death or disability of our management team. The loss of members
of our management team, or our inability to attract or retain other qualified individuals, could have a material adverse effect on our
business, results of operations and financial condition.

Exchange rate fluctuations between the U.S. dollar and the New Israeli Shekel and inflation may negatively affect our results of operations, and we may not be able to hedge our currency exchange risks successfully.

The U.S. dollar is our functional
and reporting currency. However, a portion of our operating expenses, including personnel and facilities related expenses, are incurred
in NIS. As a result, we are exposed to the risks that the NIS may appreciate relative to the U.S. dollar, or, if the NIS instead devalues
relative to the U.S. dollar, that the inflation rate in Israel may exceed such rate of devaluation of the NIS, or that the timing of such
devaluation may lag behind inflation in Israel. In any such event, the dollar cost of our operations in Israel would increase and our
dollar-denominated results of operations would be adversely affected. Given our general lack of currency hedging arrangements to protect
us from fluctuations in the exchange rates of the NIS and other foreign currencies in relation to the U.S. dollar (and/or from inflation
of such foreign currencies), we may be exposed to material adverse effects from such movements. Our exchange rate exposure may change
over time as our business evolves and could result in increased